21.99
1.23 (5.92%)
| Penutupan Terdahulu | 20.76 |
| Buka | 20.76 |
| Jumlah Dagangan | 632,389 |
| Purata Dagangan (3B) | 427,673 |
| Modal Pasaran | 1,074,374,528 |
| Harga / Pendapatan (P/E Ke hadapan) | 185.19 |
| Harga / Jualan (P/S) | 11.52 |
| Harga / Buku (P/B) | 3.14 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Keuntungan | -11.86% |
| Margin Operasi (TTM) | -5.09% |
| EPS Cair (TTM) | -0.190 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 29.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.64% |
| Nisbah Semasa (MRQ) | 4.73 |
| Aliran Tunai Operasi (OCF TTM) | 14.63 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 39.10 M |
| Pulangan Atas Aset (ROA TTM) | -0.79% |
| Pulangan Atas Ekuiti (ROE TTM) | -2.52% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Bercampur | |
| Stok | BioLife Solutions, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.5 |
| Purata | -0.63 |
|
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.84% |
| % Dimiliki oleh Institusi | 100.53% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |